Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Annals of the Rheumatic Diseases(1)
Biologics: Targets and Therapy(1)
Journal of Clinical Rheumatology(1)
Origen
scopus(3)
A Consensus Position Paper from REAL-PANLAR Group about the Methodological Approach for the Accbkp_reditation Process of Centers of Excellence in Rheumatoid Arthritis in Latin America
ArticleAbstract: Background By 2015, the World Health Organization reported that 1% of the world population sufferedPalabras claves:accbkp_reditation, Latin America, quality of health care, Rheumatoid Arthritis, standard of careAutores:Caballero-Uribe C.V., Cardiel M.H., Castro-Moreno C., Claudio M. Galarza-Maldonado, Diana Carolina Buitrago-García, Massardo L., Pineda-Villaseñor C., Santos-Moreno P., Soriano E.R., Villarreal L.Fuentes:scopusExperience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic
OtherAbstract:Palabras claves:Arthritis, epidemiology, health services research, rheumatoidAutores:Aza A., Castiblanco-Montañez R.A., Chavez-Chavez J., Diana Carolina Buitrago-García, Hernández-Zambrano S.M., Rivera-Triana D.P., Rojas-Villarraga A., Santos-Moreno P., Villarreal L.Fuentes:scopusIs Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
ArticleAbstract: Purpose: Tofacitinib is recommended for treatment of rheumatoid arthritis (RA) in patients with modePalabras claves:biologics, Rheumatoid Arthritis, tofacitinib, TreatmentAutores:Claudio M. Galarza-Maldonado, Ibata L., Martinez S., Rivero M., Rodríguez-Florido F., Rojas-Villarraga A., Santos-Moreno P., Villarreal L.Fuentes:scopus